Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Delayed Nasdaq
Other stock markets
 14:30:00 20/05/2024 BST 		5-day change 1st Jan Change
1.48 USD -2.63% Intraday chart for OKYO Pharma Limited 0.00% -16.38%
03-22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
03-22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI

Evolution of the average Target Price on OKYO Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

07089419718b3cdb15719bbd.l9kUnbQYfQjWEATGn9eG0W3pXO2N-6jAZUyzUBGSM3s.opZtqOB5MkyFPTXx9obR6TisBd3KosGqKTv0BUL-fS7D4XL38kcTRrchPA~0bb6ae945a9743913046b932d8758db6

Analyst Recommendations on OKYO Pharma Limited

H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
HC Wainwright Initiates Coverage on OKYO Pharma with Buy Rating, $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.52 USD
Average target price
7 USD
Spread / Average Target
+360.53%
High Price Target
7 USD
Spread / Highest target
+360.53%
Low Price Target
7 USD
Spread / Lowest Target
+360.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering OKYO Pharma Limited

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. Consensus OKYO Pharma Limited